S (EVAX)

Role: Chief Executive Officer
Signature: /s/ Michael Baird, Attorney-in-Fact
Issuer symbol: EVAX
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 21:06:30 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Evaxion A/S	Chief Executive Officer	DR. NEERGAARDS VEJ 5F, HORSHOLM, DENMARK	/s/ Michael Baird, Attorney-in-Fact	18 Mar 2026	0001828253

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	EVAX	Ordinary Shares						2,286,150	18 Mar 2026	By James Noble	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EVAX	Warrants							18 Mar 2026	Ordinary Shares	2,500,000	$0.1200	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Noble is Dr. Tayton-Martin's spouse.
F2	Vesting is 1/36 per month over 36 months from the initial exercise date indicated.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney. This initial holding statement has been made for Helen Katrina Tayton-Martin using the Issuer's CIK codes to satisfy Form 3 filing requirements. An amendment will be filed for Dr. Tayton-Martin upon receipt of her CIK filer codes from the SEC.